Rapid Micro Biosystems, Inc. (RPID) has a consensus analyst rating of Buy, based on 4 analysts covering the stock. Of those, 2 recommend buying, 2 recommend holding, and 0 recommend selling.
The analyst consensus price target for RPID is $8.00, representing a +265.3% upside from the current price of $2.19. Price targets range from a low of $8.00 to a high of $8.00.
